Immunotherapy Industry Statistics

The immunotherapy industry is anticipated to experience significant growth in the coming years due to the increasing prevalence of cancer and other autoimmune diseases, coupled with advancements in research and technology.

In this post, we explore the dynamic landscape of the immunotherapy industry, backed by a series of compelling statistics that shed light on the market trends and growth projections. From the dominance of North America in the global immunotherapy drug market to the rapid rise of segments like vaccines and immuno-oncology antibodies, the industry is set for significant advancements in the coming years. Join us as we dissect key data points and insights driving the evolution of immunotherapy on a global scale.

Statistic 1

"The market is expected to grow at a CAGR of 11.51% from 2020 to 2025."

Sources Icon

Statistic 2

"North America dominates the global immunotherapy drug market with a 45% share."

Sources Icon

Statistic 3

"Monoclonal antibodies dominated the global market and acquired a share of 77.4% in 2018."

Sources Icon

Statistic 4

"The immuno-oncology antibodies segment is expected to grow at a CAGR of 10.6% from 2019 to 2026."

Sources Icon

Statistic 5

"In 2018, the infectious disease segment held an 18.4% share in the world immunotherapy drugs market."

Sources Icon

Statistic 6

"The vaccines segment is expected to be the fastest-growing segment in the immunotherapy market with a CAGR of 11.2% from 2018 to 2026."

Sources Icon

Statistic 7

"As per the reports, over 3,400 immunotherapy agents were in development stage in 2019."

Sources Icon

Statistic 8

"The Chinese immunotherapy market is expected to witness a CAGR of 20.3% between 2021-2026."

Sources Icon

Statistic 9

"The market of immunotherapy in cancer treatment is expected to reach $27 billion by 2023."

Sources Icon

Statistic 10

"PD-1/PD-L1 inhibitors dominated the cancer immunotherapy market and accounted for 54% of the global shares."

Sources Icon

Statistic 11

"The immunotherapy drugs market in Europe is expected to grow at a CAGR of 14% from 2019 to 2025."

Sources Icon

Statistic 12

"The global cancer immunotherapy market size was valued at $57.92 billion in 2020, and is estimated to reach $115.39 billion by 2028."

Sources Icon
The statistics presented indicate a strong and growing trend in the immunotherapy industry, with significant market growth projected for various segments such as monoclonal antibodies, vaccines, and immuno-oncology antibodies. North America currently holds a dominant position in the global market, while regions like Europe and China are expected to experience substantial growth in the coming years. The market for cancer immunotherapy, especially PD-1/PD-L1 inhibitors, shows promising prospects and is set to reach significant revenue milestones by 2023 and beyond. With a large number of immunotherapy agents in the development stage, the industry is poised for further innovation and expansion, making it a key area of focus for healthcare advancements in the near future.

... Before You Leave, Catch This! 🔥

Your next business insight is just a subscription away. Our newsletter The Week in Data delivers the freshest statistics and trends directly to you. Stay informed, stay ahead—subscribe now.

Sign up for our newsletter and become the navigator of tomorrow's trends. Equip your strategy with unparalleled insights!